Benjamin W. Stango

As part of the firm’s borrower finance team, Ben works closely with CFOs, treasurers, heads of capital markets, general counsels, and in-house legal teams to help finance the future of their businesses. He counsels a wide range of clients, including public and private companies, private equity sponsors, venture capital firms, nonprofits (including community development financial institutions), and high-net-worth individuals.

Ben advises on syndicated and bilateral credit facilities, note offerings (senior, subordinated, secured, convertible, and hybrid), leveraged buyouts, asset-based lending, private credit and direct lending transactions, factoring and receivables financings, commercial paper programs, intercompany loans, and venture debt financings. His work spans industries including healthcare, aerospace, retail, and life sciences, with deal sizes from under $1 million to more than $6 billion. His MBA from The Wharton School helps drive his commercial approach to legal strategy.

At Morgan Lewis, Ben serves on the Philadelphia Professional Recruiting Committee and has participated in firmwide leadership through the Global Committee on Associates, ESG Working Group, and multiple other committees.

Ben remains active in the Greater Philadelphia civic and legal communities. He serves on the board of the Support Center for Child Advocates, where he volunteers as a Child Advocate pro bono attorney, and on the Board of Governors of the Philadelphia Bar Association, where he co-chairs the Large Firm Associates Committee. Ben also advises a range of civic and political organizations throughout the region.

Ben is the only Chambers and Partners ranked finance associate in Greater Philadelphia and was one of only four lawyers shortlisted as a Rising Star by IFLR in 2025.

Notable Public Company Representations

• Cencora, Inc. (NYSE: COR), one of the largest global pharmaceutical sourcing and distribution services companies, in connection with general treasury matters:
• Its $4.5 billion senior multicurrency cross-border revolving credit facility
• Term loan and senior note financings for its $6.275 billion acquisition of Alliance Healthcare from Walgreens Boots Alliance
• A global reorganization involving legal entities in multiple countries including the United Kingdom, Singapore, Australia, Switzerland, and Luxembourg
• Finance matters related to its $1.29 billion acquisition of PharmaLex, a provider of specialized services for the pharma, biotech, and medtech industries, from funds advised by AUCTUS Capital Partners AG
• The company’s global rebranding from “AmerisourceBergen Corporation” to “Cencora, Inc”
• Its entry into its multi-billion-dollar commercial paper program
• Finance matters related to its acquisition of Retina Consultants of America including a $1.8 billion senior note offering, a $1.5 billion term loan facility, and a $1 billion 364-day revolving credit facility
• More than $10 billion in senior note offerings and other financings since 2017
• Arcadium (formerly Livent Corporation and now a subsidiary of Rio Tinto):
• $500 million senior secured revolving credit facility
• $225 million of convertible senior “green” notes due 2025
• $252.4 million follow-on common stock offering
• FMC Corporation (NYSE: FMC), a global agricultural sciences company, in connection with general treasury matters and
• Its $2 billion senior revolving credit facility
• More than $1 billion in senior note offerings since 2017
• Walker & Dunlop (NYSE: WD)
• $400 million senior note offering
• $450 million term loan and $50 million revolving loan facilities
• CompoSecure Inc (NASDAQ: CMPO) regarding its credit facility with JPMorgan Chase and the issuance of certain senior notes
• Axon Enterprise, Inc. (NASDAQ: AXON) in connection with its credit facility with JPMorgan Chase
• ADMA Biologics (NASDAQ: ADMA) in connection with its 2022 debt refinancing and 2023 asset-based credit facility with Ares Capital
• FirstEnergy Corp., an electric utility, in connection with its revolving credit facilities and general treasury matters

Notable Private Equity Representations

• Sun Capital Partners in connection with numerous acquisition financings
• LLR Partners in connection with numerous acquisition financings
• Walnut Grove Capital Partners in connection with numerous acquisition financings

Other Notable Representations

• A national health insurance company in connection with its $300 million credit facility and general treasury matters
• Reinvestment Fund, a nonprofit organization and community development financial institution, in connection with numerous loans to fund its mission-driven investments
• A banking executive in his personal capacity in a material amendment and renegotiation of two large, personal, private banking loans with his existing lender
• PAE Inc. in connection with a $740 million senior secured term loan facility and a $175 million senior secured asset-based revolving credit facility
• A national nonprofit organization that collects, stores, and distributes biological materials for research and development, as borrower, in a $30 million credit facility extended by an international bank
• An early stage space exploration and technology company in connection with a $58 million growth capital term loan